
Ductal prostate cancer: Clinical features and outcomes from a multicenter retrospective analysis and overview of the current literature
Author(s) -
Salvatore Cozzi,
Lilia Bardoscia,
M. Hassan Najafi,
Şefik İğdem,
Luca Triggiani,
Stefano Maria Magrini,
A. Botti,
Ferràn Guedea E.,
Laura Melocchi,
Patrizia Ciammella,
C. Iotti,
Cristina Gutierrez M.
Publication year - 2022
Publication title -
current urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.476
H-Index - 13
eISSN - 1661-7657
pISSN - 1661-7649
DOI - 10.1097/cu9.0000000000000118
Subject(s) - medicine , prostate cancer , radiation therapy , retrospective cohort study , oncology , androgen deprivation therapy , prostate , disease , adenocarcinoma , cancer , urology
The aim of the study is to evaluate clinical features and outcomes after different therapeutic strategies for ductal prostate adenocarcinoma (DPC), a rare but aggressive subtype of invasive prostate cancer (PCa) accounting for, in the pure and mixed form, 1% or less and 5% or less, respectively, of all the newly diagnosed PCa.